LaVoieHealthScience Announces Appointment of Gemma Bakx as Senior Vice President of Investor Relations and Financial Communications

Rhea-AI Summary

LaVoieHealthScience has appointed Gemma Bakx as Senior Vice President of Investor Relations and Financial Communications. With over two decades of experience in investor relations, Bakx will play a critical role in enhancing the agency's investor relations infrastructure. Under the leadership of Donna L. LaVoie, Bakx's expertise in ESG and sustainability is expected to bolster the firm's strategic growth. LaVoieHealthScience has seen impressive double-digit growth and has formed a strategic alliance with Omnicom Group. The agency is well-positioned for continued expansion in the health and science sectors.

Positive

• Appointment of Gemma Bakx to enhance investor relations and financial communications.
• Bakx's extensive experience is expected to strengthen agency's offerings.
• Agency's impressive double-digit growth in recent years signals strong market position.
• Strategic alliance with Omnicom Group broadens global scale and capabilities.

Negative

• Potential concerns regarding continuity with the new leadership change.
• Experience gaps could pose challenges in adapting to evolving investor expectations.

Further Strengthens IR Leadership Team and Supports Integrated Strategic Communications Capabilities and Continued Business Growth

BOSTON & NEW YORK--(BUSINESS WIRE)-- LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of Gemma Bakx as Senior Vice President of Investor Relations and Financial Communications. Gemma brings a comprehensive understanding of global equities markets, clients’ needs and investment styles, with focus on ESG integration into investment portfolios. She will be instrumental in building out the agency’s investor relations infrastructure, team, and practice.

Leveraging Gemma’s extensive industry experience, she will partner with LHS’ and its clients’ investor relations teams on integrated communications reporting in to President & CEO, Donna L. LaVoie. Gemma is multi-lingual and has a strong track record in engagement with institutional investors and governance specialists. She has had an exciting, two-decade long investor relations career at investor relations and capital markets advisory firms, such as Makinson Cowell US Ltd, currently owned by Lazard in London.

Donna L. LaVoie, President and CEO of LaVoieHealthScience said, “Gemma joins our agency as the global investor relations lead at a momentous time. As a number of companies have matured to become commercial entities, adding a senior investor relations and financial communications executive with extensive experience in leading teams and counseling clients on 21^st century issues, including ESG and sustainability, investor perception, and targeting, is critical to the evolution of our client base.”

Gemma added, “With LaVoieHealthScience’s impressive double-digit growth record in recent years, the firm is very well positioned to keep building momentum, expand the investor relations offerings, and continue to grow as an ever-better, trusted, and integrated advisor for its clients. I could not be more thrilled to join at this time.”

Gemma has a legal background, with a graduate degree from Queen Mary University of London. She is GRI-certified in Sustainability Reporting Standards and holds certifications from Harvard Business School Online in Disruptive Strategy and Sustainable Business Strategy.

About LaVoieHealthScience

LaVoieHealthScience advances health and science innovations through strategic communications. The agency offers fully integrated public relations, investor relations, marketing, and digital services. LaVoieHealthScience been in business for over 20 years, has won over 50 public relations and investor relations awards, developed over 325 communications plans, and has doubled in size since 2017. The firm cemented a global strategic alliance with Omnicom Public Relations Group (OPRG), a division of Omnicom Group (NYSE:OMC) in January 2020, broadening its global scale, reach, and capabilities.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220316005950/en/

Agency Contact:

Lisa DeScenza

Vice President, Integrated Communications & Head of BD & Marketing

(617) 351-0243

ldescenza@lavoiehealthscience.com



Media Contact:

Shani Lewis

Account Manager, PR & Media Relations

(617) 865-5554

slewis@lavoiehealthscience.com

Source: LaVoieHealthScience

FAQ

What is the significance of Gemma Bakx's appointment at LaVoieHealthScience?

Gemma Bakx's appointment as Senior VP of Investor Relations is significant as it aims to strengthen the agency's investor relations capabilities at a crucial time.

How will Gemma Bakx impact LaVoieHealthScience's growth?

With her extensive experience in ESG and capital markets, Gemma Bakx is expected to enhance the agency's investor relations offerings and support continued business growth.

What is LaVoieHealthScience's relationship with Omnicom Group?

LaVoieHealthScience has a strategic alliance with Omnicom Group, established in January 2020, which broadens its global reach and capabilities.

What does the growth of LaVoieHealthScience indicate for investors?

The agency's impressive double-digit growth reflects a strong market position and could indicate promising opportunities for investors.